ÂÜÀòÂÒÂ×

Michael Gennaco has over 20 years of experience in the biotechnology industry. Michael began their career at MassBiologics in 1998 as a QC Analyst I/ II. Michael then moved to Lonza (Formerly Cambrex Biosciences Hopkinton) in 2004 as a QC Analyst II. In 2005, they joined Shire Pharmaceuticals as a QC Analyst, where they performed HPLC Analyses and supported the release of lots of biologic Active Pharmaecutical Ingredients (API) and finished products. From 2010 to 2014, they worked at Smartcells, Inc. /Merck as a Research Associate II, developing and qualifying HPLC, UPLC and UPLC-MS methodology for analysis of synthetically altered peptide in GCP Phase I clinical laboratory. Michael then worked at Eliassen Group for Genzyme, a Sanofi Company as a Technical Writing and Analytical Consultant from 2014 to 2015. In 2016, they worked at AKSTON BIOSCIENCES CORPORATION as an Analytical and Technical Writing Consultant. From 2017 to 2019, they worked at Artech Information Systems as a Process Validation Coordinator/ Technical Writer. Michael then joined DPS Group Global in 2019 as a Validation Engineer. Currently, they are working at Akston Biosciences Corporation as Manager Quality Control EM and Material Control and Quality Control Scientist.

Michael Gennaco obtained a Bachelor of Science (B.S.) in Chemistry from Ithaca College in 1997, and a Master of Science (M.S.) in Chemistry from UMass Boston in 2013.